Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tuberculosis Research of INA-RESPOND On Drug Resistance

NCT02758236 is registered in ClinicalTrials.gov with Ina-Respond as lead sponsor.

NCT NCT02758236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02758236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tuberculosis Research of INA-RESPOND On Drug Resistance
Lead sponsor
Ina-Respond
Phase
Observational
Overall status
Completed
Start date
February 13, 2017
Completion date
April 26, 2021
Enrollment
490 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

lung tuberculosis, mdr tb